CVS Health price target lowered to $109 from $111 at TD Cowen

TD Cowen analyst Charles Ryhee lowered the firm’s price target on CVS Health to $109 from $111 and keeps an Outperform rating on the shares. The firm said while we continue to like CVS’s long-term outlook, we lower our ests and target slightly to reflect our revised assumptions. That said, we believe at its current valuation these headwinds are fully priced in.